JP2017536124A5 - - Google Patents

Download PDF

Info

Publication number
JP2017536124A5
JP2017536124A5 JP2017527259A JP2017527259A JP2017536124A5 JP 2017536124 A5 JP2017536124 A5 JP 2017536124A5 JP 2017527259 A JP2017527259 A JP 2017527259A JP 2017527259 A JP2017527259 A JP 2017527259A JP 2017536124 A5 JP2017536124 A5 JP 2017536124A5
Authority
JP
Japan
Prior art keywords
amino acid
purified mutant
mutant pneumolysin
pneumolysin polypeptide
polypeptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017527259A
Other languages
English (en)
Japanese (ja)
Other versions
JP6734274B2 (ja
JP2017536124A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/061859 external-priority patent/WO2016081839A1/en
Publication of JP2017536124A publication Critical patent/JP2017536124A/ja
Publication of JP2017536124A5 publication Critical patent/JP2017536124A5/ja
Application granted granted Critical
Publication of JP6734274B2 publication Critical patent/JP6734274B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017527259A 2014-11-21 2015-11-20 ニューモリシン突然変異体とその利用方法 Active JP6734274B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462082848P 2014-11-21 2014-11-21
US62/082,848 2014-11-21
PCT/US2015/061859 WO2016081839A1 (en) 2014-11-21 2015-11-20 Pneumolysin mutants and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2017536124A JP2017536124A (ja) 2017-12-07
JP2017536124A5 true JP2017536124A5 (cg-RX-API-DMAC7.html) 2018-12-27
JP6734274B2 JP6734274B2 (ja) 2020-08-05

Family

ID=56014598

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017527259A Active JP6734274B2 (ja) 2014-11-21 2015-11-20 ニューモリシン突然変異体とその利用方法

Country Status (20)

Country Link
US (1) US10562941B2 (cg-RX-API-DMAC7.html)
EP (2) EP3220937B1 (cg-RX-API-DMAC7.html)
JP (1) JP6734274B2 (cg-RX-API-DMAC7.html)
KR (1) KR102304828B1 (cg-RX-API-DMAC7.html)
CN (1) CN107106635B (cg-RX-API-DMAC7.html)
AU (1) AU2015349787B2 (cg-RX-API-DMAC7.html)
DK (1) DK3220937T3 (cg-RX-API-DMAC7.html)
ES (1) ES2993430T3 (cg-RX-API-DMAC7.html)
FI (1) FI3220937T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20241627T1 (cg-RX-API-DMAC7.html)
HU (1) HUE069200T2 (cg-RX-API-DMAC7.html)
LT (1) LT3220937T (cg-RX-API-DMAC7.html)
MX (1) MX381872B (cg-RX-API-DMAC7.html)
PL (1) PL3220937T3 (cg-RX-API-DMAC7.html)
PT (1) PT3220937T (cg-RX-API-DMAC7.html)
RS (1) RS66221B1 (cg-RX-API-DMAC7.html)
SI (1) SI3220937T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202400482T1 (cg-RX-API-DMAC7.html)
WO (1) WO2016081839A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201703881B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012134975A1 (en) 2011-03-28 2012-10-04 St. Jude Children's Research Hospital Methods and compositions employing immunogenic fusion proteins
EP3562838A2 (en) 2016-12-28 2019-11-06 Henriques Normark, Birgitta Microparticles from streptococcus pneumoniae as vaccine antigens
CN110967482B (zh) * 2018-09-30 2023-04-07 重庆市畜牧科学院 一种山羊化脓隐秘杆菌感染检测试剂盒及其检测方法
CN113264999B (zh) * 2021-04-29 2023-02-28 星济生物(苏州)有限公司 中和肺炎链球菌溶血素蛋白的抗原结合蛋白及其用途
CA3231684A1 (en) 2021-09-09 2023-03-16 Affinivax, Inc. Multivalent pneumococcal vaccines
KR20240149460A (ko) 2021-11-18 2024-10-14 매트리박스, 인크. 면역원성 융합 단백질 조성물 및 이의 사용 방법
CN115927420A (zh) * 2022-05-27 2023-04-07 贵州省畜牧兽医研究所 一种溶血素重组表达及间接elisa检测方法及应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686102A (en) 1984-04-12 1987-08-11 American Cyanamid Company Multivalent pneumococcal vaccine and preparation thereof
DE68929323T2 (de) 1988-12-16 2002-04-18 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Pneumolysin-mutanten und pneumokokken-impfstoffe daraus
US6716432B1 (en) 1988-12-16 2004-04-06 James Cleland Paton Pneumolysin mutants and pneumococcal vaccines made therefrom
US5854416A (en) 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US5565204A (en) 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
CA2221480A1 (en) 1995-06-07 1996-12-19 The Regents Of The University Of Minnesota Mutants of streptococcal toxin a and methods of use
WO1999003884A2 (en) 1997-07-21 1999-01-28 North American Vaccine, Inc. Modified immunogenic pneumolysin, compositions and their use as vaccines
US6224880B1 (en) 1997-09-24 2001-05-01 Merck & Co., Inc. Immunization against Streptococcus pneumoniae using conjugated and unconjugated pneumoccocal polysaccharide vaccines
US6903184B1 (en) 1998-03-02 2005-06-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Multiple antigenic peptides immunogenic against Streptococcus pneumonia
WO2000005378A2 (en) 1998-07-22 2000-02-03 Id-Lelystad Instituut Voor Dierhouderij En Diergezondheid B.V. Streptococcus suis vaccines and diagnostic tests
DE69940439D1 (de) 1998-12-21 2009-04-02 Medimmune Inc Streptococcus pneumoniae proteine und immunogene fragmente für impstoffe
US6887480B1 (en) 1999-06-10 2005-05-03 Medimmune, Inc. Streptococcus pneumoniae proteins and vaccines
AU2002351623A1 (en) 2001-12-20 2003-07-09 Shire Biochem Inc. Streptococcus antigens
US7217791B2 (en) 2002-11-07 2007-05-15 Synergy America, Inc. Compositions and methods for treating or preventing pneumococcal infection
WO2005076696A2 (en) 2004-02-13 2005-08-25 Sanofi Pasteur Limited Pneumolysin derivatives
WO2005108419A1 (en) 2004-05-07 2005-11-17 Lea-Ann Kirkham Mutant cholesterol-binding cytolysin proteins
GB0410220D0 (en) * 2004-05-07 2004-06-09 Kirkham Lea Ann Mutant pneumolysin proteins
WO2007144647A2 (en) 2006-06-15 2007-12-21 Timothy John Mitchell Adjuvant compositions
CA2683748C (en) 2007-04-13 2016-02-16 The Board Of Regents Of The University Of Oklahoma Mutants of cholesterol-dependent cytolysins and uses thereof
CN106008679A (zh) 2008-12-24 2016-10-12 荷兰王国卫生福利和运动部国家公共卫生和环境研究所 修饰的肺炎链球菌溶血素(ply)多肽
US9649372B2 (en) * 2009-12-22 2017-05-16 Sanofi Pasteur Limited Immunogenic compositions and related methods
CL2010001216A1 (es) * 2010-11-08 2011-01-28 New Tech Copper S P A Sistema para confinar el espacio sobre el electrolito en una celda de electro obtencion y evacuar los aerosoles generados, que comprende un confinador insertado en cada anodo, con un par de proyecciones flexibles y un par de perfiles en angulo, y ductos longitudinales con perforaciones sobre el nivel del electrolito.
WO2012134975A1 (en) 2011-03-28 2012-10-04 St. Jude Children's Research Hospital Methods and compositions employing immunogenic fusion proteins
JP6397805B2 (ja) 2015-08-28 2018-09-26 東芝メモリ株式会社 半導体製造装置およびその運転方法

Similar Documents

Publication Publication Date Title
JP2017536124A5 (cg-RX-API-DMAC7.html)
JP2015214545A5 (cg-RX-API-DMAC7.html)
IL276210B2 (en) Mers-cov vaccine
JP2015514132A5 (cg-RX-API-DMAC7.html)
JP2012000112A5 (cg-RX-API-DMAC7.html)
JP2015164424A5 (cg-RX-API-DMAC7.html)
JP2012530761A5 (cg-RX-API-DMAC7.html)
JP2012115277A5 (cg-RX-API-DMAC7.html)
JP2018520997A5 (cg-RX-API-DMAC7.html)
HRP20241627T1 (hr) Pneumolizinski mutanti i postupci za njihovu uporabu
JP2011004753A5 (cg-RX-API-DMAC7.html)
HRP20161458T1 (hr) Polipeptidi, polinukleotidi i pripravci namijenjeni upotrebi u liječenju latentne tuberkuloze
JP2011528896A5 (cg-RX-API-DMAC7.html)
FI3564378T3 (fi) Immunogeeninen koostumus
JP2013501007A5 (cg-RX-API-DMAC7.html)
JP2011528895A5 (cg-RX-API-DMAC7.html)
JP2013533273A5 (cg-RX-API-DMAC7.html)
JP2013523718A5 (cg-RX-API-DMAC7.html)
JP2011528897A5 (cg-RX-API-DMAC7.html)
JP2016504993A5 (cg-RX-API-DMAC7.html)
JP2015513318A5 (cg-RX-API-DMAC7.html)
JP2014529399A5 (cg-RX-API-DMAC7.html)
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
JP2017513849A5 (cg-RX-API-DMAC7.html)
JP2019505567A5 (cg-RX-API-DMAC7.html)